Intellectual Property India Publishes Patent Application for 'Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens And Uses Thereof' Filed by Pfizer Inc.

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517097515 A) filed by Pfizer Inc., New York, on Oct. 9, for 'immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof.'

Inventor(s) include Bhetuwal, Bishwa Raj; Dutta, Kaushik; Gu, Jianxin; Kapil, Sunayana; Kim, Jin-Hwan; Moran, Justin Keith; Singh, Suddham; and Yang, Yuying.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates), kits comprising said immunoge...